SCHEMBL7671279

SCHEMBL7671279

CCOC(=O)c1ccc2nc(C(C)C)n(Cc3ccccc3Cl)c2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5AP P20292 6/20 0.54
▸ PDE2A O00408 2/20 0.52
▸ PDE10A Q9Y233 1/20 0.52
▸ ALDH1A1 P00352 4/20 0.49
▸ KDM4E B2RXH2 3/20 0.49
▸ MAPT P10636 2/20 0.49
▸ MAPK1 P28482 1/20 0.49
▸ TDP1 Q9NUW8 1/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ GAA P10253 2/20 0.46
▸ LMNA P02545 1/20 0.46
▸ HDAC1 Q13547 1/20 0.46
▸ HDAC6 Q9UBN7 1/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ CYP2C9 P11712 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ PTGES O14684 2/20 0.45
▸ ALOX5 P09917 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6169005 0.88 PDE2A (0.55) ALOX5APPDE2APDE10AALDH1A1KDM4E
SCHEMBL7676640 0.86 PDE2A (0.53) PDE2APDE10AALDH1A1KDM4EMAPT
SCHEMBL6168983 0.85 PDE2A (0.56) ALOX5APPDE2APDE10AALDH1A1KDM4E
SCHEMBL7668569 0.84 TDP1 (0.52) PDE2APDE10AALDH1A1KDM4EMAPT
SCHEMBL7673764 0.83 PDE2A (0.51) ALOX5APPDE2APDE10AALDH1A1KDM4E
SCHEMBL6168511 0.82 ALOX5AP (0.51) ALOX5APPDE2APDE10AALDH1A1KDM4E
SCHEMBL169971 0.82 KDM4E (0.53) PDE2APDE10AALDH1A1KDM4EMAPT
SCHEMBL6169187 0.82 AGTR1 (0.52) PDE2APDE10AALDH1A1KDM4EMAPT
SCHEMBL6170082 0.82 PDE2A (0.49) ALOX5APPDE2APDE10AALDH1A1KDM4E
SCHEMBL6172337 0.79 PPARG (0.64) ALOX5APPDE2AALDH1A1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6352985-B1 CARDIOVASCULAR DISORDERS OR GASTROINTESTINAL DISORDERS, DIABETES (TYPE II DIABETES), DIABETIC COMPLICATIONS METHOD FOR LOWERING THE BLOOD SUGAR LEVEL OF A PATIENT, FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-03-05 — — US disclosed
EP-1132087-A1 REMEDIES FOR POLYCYSTIC OVARY SYNDROME FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-09-12 — — EP disclosed
US-6166219-A Benzimidazole derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-12-26 — — US disclosed
EP-0882718-A1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-09 — — EP disclosed
Send feedback